In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

New article by Katarzyna Jedynak PhD for Chemia & Biznes magazine

Innovative solutions are not only original products that break thinking patterns, but also those that Czytaj dalej

Weronika Witkowska on the protection of solutions using artificial intelligence

Patpol has picked up the Prosecution Firm of the Year award for Poland at the Czytaj dalej

Patpol and Patpol Legal at 8th International Congress of Family Businesses

It is estimated that over 90% of Polish companies are family businesses. How should a Czytaj dalej